Literature DB >> 19889344

Urinary NT-proBNP. A valuable marker in the assessment of patients with essential hypertension.

Esther Roselló-Lletí1, Miguel Rivera, Raquel Cortés, Lilian Grigorian, Vicente Miró, Federico Soria, Manuel Portolés, Vicente Bertomeu.   

Abstract

The aim was to evaluate the usefulness of urinary N-terminal fragment of B-type natriuretic peptide (NT-proBNP) measurement for predicting the presence of left ventricular hypertrophy (LVH) in 160 asymptomatic patients with essential hypertension. The urinary NT-proBNP/creatinine ratio was higher in patients with LVH than in either those without LVH (P< .0001) or control subjects (P< .0001). Multivariate linear regression analysis identified age (P=.034), left ventricular mass index (P=.026) and serum NT-proBNP level (P=.001) as predictors of the urinary peptide level. The area under the curve for the NT-proBNP/creatinine ratio was 0.71+/-0.04 (P< .0001) for identifying LVH. Logistic regression analysis showed that the NT-proBNP: creatinine ratio was a predictor of LVH (odds ratio=4.074; P=.009). In conclusion, the urinary NT-proBNP concentration is a new marker that could be useful for identifying LVH in subjects with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889344     DOI: 10.1016/s1885-5857(09)73360-2

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  2 in total

1.  Urinary N-terminal pro-brain natriuretic peptide: prognostic value in patients with acute chest pain.

Authors:  Stefanie Reynen; Michael Schlossbauer; Ute Hubauer; Julian Hupf; Arno Mohr; Evelyn Orso; Markus Zimmermann; Andreas Luchner; Lars S Maier; Stefan Wallner; Carsten G Jungbauer
Journal:  ESC Heart Fail       Date:  2021-04-06

2.  Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.

Authors:  Keisuke Yamasaki; Jun Hata; Tomomi Ide; Takuya Nagata; Satoko Sakata; Daigo Yoshida; Takanori Honda; Yoichiro Hirakawa; Toshiaki Nakano; Takanari Kitazono; Hiroyuki Tsutsui; Toshiharu Ninomiya
Journal:  Environ Health Prev Med       Date:  2021-04-12       Impact factor: 3.674

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.